Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

hexane/saratani

Kiungo kimehifadhiwa kwenye clipboard
10 matokeo

Angelicae sinensis extracts useful for treatment of cancers

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION The invention mainly relates to a new use of an acetone extract, chloroform extract or hexane extract of Angelicae sinensis and the active components purified therefrom in the treatment of cancers. Cancers are abnormal cell proliferations that result from the accumulation
FIELD OF THE INVENTION The present invention discloses a novel method to isolate a natural flavonoid; inoscavin A indicated in formula 1, from mushroom F. fastuosus, having promising antiprolifertive activity on rhabdomyosarcoma and thereby communicates its application to use it as a medicinal

Anti-cancer active substance from Antrodia camphorata, method for preparing the same and use thereof

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel anti-cancer compound identified in mycelium of Antrodia camphorata, the methods of cultivation, and applications of the said compound. To be more specific, the extracted compound is a bioactive anti-cancer

L-buthionine-S-sulfoximine and methods of making

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
TECHNICAL FIELD This invention relates to separating the known glutathione biosynthesis inhibitor L-buthionine-SR-sulfoximine into its pure diastereoisomers. BACKGROUND OF THE INVENTION Glutathione (gamma-L-glutamyl-L-cysteinylglycine) is synthesized by the sequential action of the enzymes

L-buthionine-S-sulfoximine and methods of making

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
TECHNICAL FIELD This invention relates to separating the known glutathione biosynthesis inhibitor L-buthionine-SR-sulfoximine into its pure diasteroisomers. BACKGROUND OF THE INVENTION Glutathione (gamma-L-glutamyl-L-cysteinylglycine) is synthesized by the sequential action of the enzymes

Green synthesis of katononic acid nanosheets

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND 1. Field The disclosure of the present patent application relates to katononic acid nanosheets, and particularly to a method of green synthesis of katononic acid nanosheets. 2. Description of the Related Art According to some estimates, cancer is responsible for around 15% of annual

Glycoproteins and processes for their production

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to novel glycoproteins obtained from an extract or a supernatant of culture medium of reticulo-endothelial cells, lymphoblasts, leukemia cells or fibroblasts of warm-blooded animals, processes for their production and

Antitumor substance

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to a new antitumor substance and, in particular, relates to a new substance having antitumor activity against certain types of tumors and containing protein, which substance is obtained from an epidermal portion of rice. 2.

Physiologically active peptides and a process for preparation thereof

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
The following examples illustrate the present invention, but it is to be understood that they are given for the purpose of illustration and not limitation. EXAMPLE 1 A medium (100 l) containing 6.0% soluble starch, 4.0% cotton seed meal, 0.2% (NH.sub.4).sub.2 SO.sub.4, 0.1% yeast extract, 0.2%

Transfer of taxol from yew tree cuttings into a culture medium over time

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION Cancer is one of the leading causes of death in our country today. Despite extensive research, a cure for cancer is not yet a reality. Taxol is known to be cytotoxic against numerous malignant tumors. The results of studies indicate that taxol has been effective against
Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge